The goal of this research study is to to learn more about the body's immune response in patients with multiple sclerosis (MS). In MS, the body's immune cells mistakenly attack an important part of the nerves of the brain and spinal cord. The immune cells responsible for attacking the nerves in MS patients is primarily the T cells. A marker was recently discovered that might specifically identify these damaging T cells from all other T cells in the body. Understanding which T cells cause the damage in MS patients and understanding more about these specific T cells may help doctors better understand how MS occurs and could possibly prevent MS in the future.
Not yet recruiting
MS Group Inclusion criteria
-diagnosis of multiple sclerosis and present to the neurology clinic for a regular checkup or are admitted to the inpatient floor with acute symptoms.
Have an active infection
Take T cell modulating drugs
Control Group Inclusion criteria -scheduled for elective surgery
without any immunological diseases. Exclusion criteria
Have an active infection.
February 16, 2023
Primary Contact Information
Lifei Hou, PhD
For more information on this trial, visit clinicaltrials.gov.
For more information and to contact the study team: